Oxi 4503

Known as: Oxi-4503, Oxi4503 
 

Topic mentions per year

Topic mentions per year

2002-2016
024620022016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
PURPOSE This pre-clinical study was designed to investigate the effect of various vascular disrupting agents (VDAs) that have… (More)
  • figure 1
  • table I
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2012
Highly Cited
2012
The use of a novel all-optical photoacoustic scanner for imaging the development of tumor vasculature and its response to a… (More)
Is this relevant?
2012
2012
PURPOSE Preclinical studies show that OXi4503 (combretastatin A1 diphosphate, CA1P) is more potent than other clinically… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • figure 1
Is this relevant?
2011
2011
Unlike normal blood vessels, the unique characteristics of an expanding, disorganized and leaky tumor vascular network can be… (More)
Is this relevant?
2010
2010
Acute myelogenous leukemias (AMLs) and endothelial cells depend on each other for survival and proliferation. Monotherapy… (More)
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2008
2008
BACKGROUND This study evaluated the therapeutic efficacy of combining vascular disrupting agents with antiangiogenic agents… (More)
  • figure 4
  • figure 1
  • figure 5
  • figure 2
  • figure 3
Is this relevant?
2006
2006
PURPOSE As first-generation small-molecule vascular disrupting agents (VDA) have begun to enter clinical trials, second… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 6
Is this relevant?
2004
2004
The mechanism of tumor cell killing by OXI4503 was investigated by studying vascular functional and morphological changes post… (More)
Is this relevant?
2003
2003
Oxi4503, which is the diphosphate prodrug of combretastatin A1, is a novel vascular targeting agent from the combretastatin… (More)
Is this relevant?
2002
2002
BACKGROUND Tubulin depolymerizing drugs, which selectively disrupt tumour neovasculature, have recently been identified. The lead… (More)
Is this relevant?